Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

The role of proBDNF-p75NTR signaling in hind limb ischemia.

Award Number: F31HL167480
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 02/01/2023
PERIOD OF PERFORMANCE END DATE: 05/31/2024

Group Awards By:

View Award Description

The role of proBDNF-p75NTR signaling in hind limb ischemia. - The role of proBDNF-p75NTR signaling in hind limb ischemia Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF have been well characterized in their contrasting roles in neuroprotection and neuroinflammation in the central nervous system respectively. Recently, BDNF and proBDNF have been shown to exist in tissues outside of the central nervous system, but their role in these tissues is still unclear. In my study it was shown that whole muscle lysate contains high levels of proBDNF and relatively low levels of mature BDNF compared to whole brain lysate. This project aims to investigate the functional role of skeletal muscle-derived proBDNF in hind limb ischemia-reperfusion (IR) injury. In this model, in which C57BL/6 mice are subjected to ligation of the right hind limb, proBDNF and its receptor p75NTR were both upregulated, and p75NTR downstream signaling pathways were activated in the ischemic muscle compared to the contralateral control limb muscles. The data further showed that treatment with LM11A-31, a p75NTR moderator, following IR injury improved perfusion of the ischemic limb compared to untreated IR controls, indicating improved endothelial function. Moreover, skeletal muscle-specific knockout of BDNF significantly improved the blood perfusion in the ischemic limb compared to wild-type mice. Previous studies have suggested that endothelial p75NTR may mediate vascular injury. Based on these results, we hypothesize that the upregulated proBDNF in skeletal muscle following IR injury may stimulate endothelial p75NTR, promoting cleavage of the intercellular domain (ICD) and subsequent inhibition of PKA-induced phosphorylation of eNOS and nitric oxide production leading to vascular dysfunction and inflammation. To test this hypothesis, mice with skeletal muscle-specific knockout of BDNF will be used to determine the role of muscle-derived proBDNF in IR injury. Then mice with endothelial-specific knockout of p75NTR will be used to examine whether endothelial p75NTR mediates IR injury. Finally, in vitro and in vivo experiments will be used to define the inhibition of PKA by the ICD of p75NTR and subsequent eNOS function being responsible for the IR injury. The results of this project will reveal a novel mechanism underlying IR injury and suggest new targets for the prevention and treatment of IR injury in patients. While under the superior intellectual guidance and support of a mentor with over 20 years of experience in the field, functional knowledge of experimental design, data analysis and interpretation, and scientific communication will be developed, leading to Ph.D. and enabling a successful and productive career in biomedical research. Experiments will be carried out using top-of-the-line research equipment in premier facilities with ample opportunities for learning, growth, and support.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$12,852 )
2025	2024	THE UNIVERSITY OF SOUTH DAKOTA	414 E CLARK ST	VERMILLION	SD	57069	CLAY	USA	Cardiovascular Diseases Research	000	2	3/25/2025	NON-COMPETING CONTINUATION	-$12,852
														Subtotal = -$12,852

Issue Date FY: 2024 ( Subtotal = $12,852 )
2024	2024	THE UNIVERSITY OF SOUTH DAKOTA	414 E CLARK ST	VERMILLION	SD	57069	CLAY	USA	Cardiovascular Diseases Research	002	2	7/30/2024	NON-COMPETING CONTINUATION	$360
2024	2024	THE UNIVERSITY OF SOUTH DAKOTA	414 E CLARK ST	VERMILLION	SD	57069	CLAY	USA	Cardiovascular Diseases Research	000	2	1/23/2024	NON-COMPETING CONTINUATION	$39,780
2024	2024	THE UNIVERSITY OF SOUTH DAKOTA	414 E CLARK ST	VERMILLION	SD	57069	CLAY	USA	Cardiovascular Diseases Research	001	2	5/20/2024	NON-COMPETING CONTINUATION	-$27,288
														Subtotal = $12,852

Issue Date FY: 2023 ( Subtotal = $39,780 )
2023	2023	UNIVERSITY OF SOUTH DAKOTA	414 E CLARK ST	VERMILLION	SD	57069	CLAY	USA	Cardiovascular Diseases Research	001	1	4/1/2023	NEW	$942
2023	2023	UNIVERSITY OF SOUTH DAKOTA	414 E CLARK ST	VERMILLION	SD	57069	CLAY	USA	Cardiovascular Diseases Research	000	1	12/9/2022	NEW	$38,838
2023	2023	UNIVERSITY OF SOUTH DAKOTA	414 E CLARK ST	VERMILLION	SD	57069	CLAY	USA	Cardiovascular Diseases Research	002	1	4/1/2023	NEW	$0
														Subtotal = $39,780

Grand Total All Awards = $39,780

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The role of proBDNF-p75NTR signaling in hind limb ischemia.

Award Number: F31HL167480

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 02/01/2023

PERIOD OF PERFORMANCE END DATE: 05/31/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer